GLP-1 receptor agonists, such as semaglutide and liraglutide, are primarily used to manage type 2 diabetes and have been shown to aid in weight loss
What is being measured Subjective recovery, training tolerance
During illness, your needs increase due to: Fever can increase insensible fluid losses and may increase fluid needs (often estimated around 10% per 1C) Respiratory symptoms causing moisture loss through breathing Reduced thirst sensation from GLP-1 effects Potential vomiting or diarrhea Adequate hydration during illness helps thin mucus secretions, supports immune function, maintains blood pressure, and prevents medication-related complications
The Broader GLP 1 Drug Market Context The controversy did not occur in isolation
The last measurable concentrations appeared at 5 days post-dose, after which the drug disappeared entirely from milk
Reported responses vary with receptor subtype, concentration, exposure time, cell model and study design